Use of a cocktail of probe substrates for drug-metabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations

Reference

• ANDERSSON, T., MINERS, J. 0., VERONESE, M. E. and BRIKETT, D. J., 1994, Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. British Journal of Clinical Pharmacology, 38, 131–137.
   Google Scholar
• AXELSSON, H., GRANHALL, C., FLOBY, E., JAKSCH, Y., SVEDLING, M. and SOHLENIUS-STERNBECK, A.-K., 2003, Rates of metabolism of chlorzoxazone, dextromethorphan, 7-ethoxycoumarin, imipramine, quinidine, testosterone and verapamil by fresh and cryopreserved rat liver slices, and some comparisons with microsomes. Toxicology in Vitro, 17, 481–488.
   Google Scholar
• BACHMANN, K., BYERS, J. and GHOSH, R., 2003, Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes. Xenobiotica, 33, 475–483.
   PubMed Web of Science ®Google Scholar
• BISSELL, D. M. and GUZELIAN, P. S., 1980, Phenotypic stability of adult rat hepatocytes in primary monolayer culture. Annals of the New York Academy of Sciences, 249, 85–98.
   Google Scholar
• BLAKEY, G. E., LOCKTON, J. A., PERRETT, J., NORWOOD, P., RUSSELL, M., AHERNE, Z. and PLUME, J., 2004, Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1. British Journal of Clinical Pharmacology, 57, 162–169.
   PubMed Web of Science ®Google Scholar
• BOGAARDS, J. J., BERTRAND, M., JACKSON, P., OUDSHOORN, M. J., WEAVER, R. J., VAN BLADEREN, P. J. and WALTHER, B., 2000, Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica, 30, 1131–1152.
   PubMed Web of Science ®Google Scholar
• BRANDON, E., RAAP, C., MEIJERMAN, I., BEIJNEN, J. and SuHELLENs, J., 2003, An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicology and Applied Pharmacology, 189, 233–246.
   PubMed Web of Science ®Google Scholar
• CHAINUVATI, S., NAFZIGER, A. N., LEEDER, J. S., GAEDIGK, A., KEARNS, G. L., SELLERS, E., ZHANG, Y ., KASHUBA, A. D., ROWLAND, E. and BERTINO, J. S., JR, 2003, Combined phenotypic assessment of cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the 'Cooperstown 5 + 1 cocktail'. Clinical Pharmacology and Therapeutics, 74, 437–447.
   PubMed Web of Science ®Google Scholar
• CHRISTENSEN, M., ANDERSSON, K., DALEN, P., MIRGHANI, R. A., MUIRHEAD, G. J., NORDMARK, A., TYBRING, G., WAHLBERG, A., YASAR, U. and BERTILSSON, L., 2003, The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes. Clinical Pharmacology and Therapeutics, 73, 517–528.
   PubMed Web of Science ®Google Scholar
• CROSS, D. M. and BAYLISS, M. K., 2000. A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development. Drug Metabolism Reviews, 32, 219–240.
   PubMed Web of Science ®Google Scholar
• DIERKS, E. A., STAMS, K. R., Lim, H. K., CORNELIUS, G., ZHANG, H. and BALL, S. E., 2001, A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug Metabolism and Disposition, 29, 23–29.
   PubMed Web of Science ®Google Scholar
• DONATO, M. T. and CASTELL, J. V., 2003, Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism. Clinical Pharmacokinetics, 42, 153–178.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1997, Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chemico-Biological Interactions, 106, 161–182.
   PubMed Web of Science ®Google Scholar
• HEWITT, N. J., FISCHER, T., ZUEHLKE, U., OESCH, F. and UTEscH, D., 2000, Metabolic activity of fresh and cryopreserved cynomolgus monkey (Macaca fascicularis) hepatocytes. Xenobiotica, 30, 665–681.
   PubMed Web of Science ®Google Scholar
• LAU, Y. Y ., SAPIDOU, E., Cm, X., WHITE, R. E. and CHENG, K. C., 2002, Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes. Drug Metabolism and Disposition, 30, 1446–1454.
   Google Scholar
• LAVE, T., DUPIN, S., SCHMITT, M., KAPPS, M., MEYER, J., MORGENROTH, B., CHOU, R. C., JAECK, D. and COASSOLO, P., 1996, Interspecies scaling of tolcapone, a new inhibitor of catechol-O-methyltransferase (COMT). Use of in vitro data from hepatocytes to predict metabolic clearance in animals and humans. Xenobiotica, 26, 839–851.
   PubMed Web of Science ®Google Scholar
• LI, A. P., Lu, C., BRENT, J. A., PHAM, C., FACKETT, A., RUEGG, C. E. and SILBER, P. M., 1999, Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chemico-Biological Interactions, 121, 17–35.
   PubMed Web of Science ®Google Scholar
• LINDBERG, R. L. and NEGISHI, M., 1989, Alteration of Mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature, 339, 632–634.
   PubMed Web of Science ®Google Scholar
• NARITOMI, Y., TERASHITA, S., KAGAYAMA, A. and SUGIYAMA, Y., 2003, Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. Drug Metabolism and Disposition, 31, 580–588.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, 0., OKUDA, K. and NEBERT, D. W., 1993, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology, 12, 1–51.
   Google Scholar
• PARKINSON, A., 1996, Biotransformations of xenobiotics. In C. D. Klaassen (ed.), Casarett Cs' Doull's Toxicology the Basic Science of Poisons (New York: McGraw-Hill), pp. 113–186.
   Google Scholar
• RENDIC, S. and DI CARLO, F. J., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metabolism Reviews, 29, 413–580.
   PubMed Web of Science ®Google Scholar
• WALSH, J. S., PATANELLA, J. E., HALM, K. A. and FACCHINE, K. L., 1995, An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin. Drug Metabolism and Disposition, 23, 869–874.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H., INouE, K., MIMURA, M., ODA, Y., GUENGERICH, F. P. and SHIMADA, T., 1996, 7-Ethoxycoumarin 0-deethylation catalysed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Biochemical Pharmacology, 51, 313–319.
   PubMed Web of Science ®Google Scholar